Nuvation Bio Files Q1 2025 10-Q Report
Ticker: NUVB · Form: 10-Q · Filed: May 7, 2025 · CIK: 1811063
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, SEC-filing
TL;DR
Nuvation Bio Q1 2025 10-Q filed. Check financials.
AI Summary
Nuvation Bio Inc. filed its quarterly report for the period ending March 31, 2025. The company, formerly Panacea Acquisition Corp, is focused on pharmaceutical preparations. Key financial data and operational details for the first quarter of 2025 are presented in this 10-Q filing.
Why It Matters
This filing provides investors and analysts with the latest financial performance and operational updates for Nuvation Bio, crucial for assessing the company's current standing and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Nuvation Bio faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial information is reported.)
- 2025-05-07 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- Nuvation Bio Inc. (company) — Filer of the 10-Q report.
- Panacea Acquisition Corp (company) — Former name of Nuvation Bio Inc.
- 20250331 (date) — End of the reporting period for the 10-Q.
- 20250507 (date) — Date the 10-Q was filed.
- 0000950170-25-065712 (accession_number) — Unique identifier for the SEC filing.
FAQ
What is the primary business of Nuvation Bio Inc.?
Nuvation Bio Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code [2834].
When was the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing concluded on March 31, 2025.
What was Nuvation Bio Inc. formerly known as?
Nuvation Bio Inc. was formerly known as Panacea Acquisition Corp, with a date of name change on April 30, 2020.
What is the SEC file number for this filing?
The SEC file number for this filing is 001-39351.
Where is Nuvation Bio Inc. located?
Nuvation Bio Inc. is located at 357 Tehama Street, Floor 3, San Francisco, CA 94103.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Nuvation Bio Inc. (NUVB).